Intuitive Surgical IncBaron Capital expects mid-teens revenue growth for many years, indicating sustained demand for Intuitive Surgical's products.

Baron Capital's Health Care Fund remains positive on Intuitive Surgical's long-term growth outlook despite recent share declines. The fund stated that Intuitive Surgical can continue to grow revenue at a mid-teens rate for many years, even as first-quarter U.S. system placements fell short of expectations and medical device stocks broadly underperformed. Concerns over decelerating health care utilization following the expiration of Affordable Care Act subsidies and potential Medicaid work requirements in 2027 contributed to the stock's weakness. Intuitive Surgical shares closed at $375.41 on August 3, 2026, with a one-month return of negative 13.53% and a 52-week decline of 26.60%, giving the company a market capitalization of $132.62 billion. The Baron Health Care Fund gained 11.99% in the second quarter of 2026, outperforming the Russell 3000 Health Care Index's 10.48% gain but trailing the broader Russell 3000 Index's 15.44% return.
Intuitive Surgical IncBaron Capital expects mid-teens revenue growth for many years, indicating sustained demand for Intuitive Surgical's products.